UNPCF Korea (CEO: Han Junghoon) and U-Mine Korea Co., Ltd. (CEO: Yoo Main) Unveil Pioneering Biotechnology and Advanced Biotech Equipment at the UK House of Lords
On September 12, 2024, U-Mine Korea presented cutting-edge biotechnologies and advancements in bio-medical technology at the invitation of the UK House of Lords, held at the Houses of Parliament in London. This presentation marked a significant milestone in the global bio and medical technology sectors, highlighting innovations that will shape the future of healthcare.
In 2021, U-Mine Korea gained attention by forming a pioneering technology partnership with UNPCF, the first of its kind within the aesthetics industry. This recent invitation to the UK House of Lords reflects the success of their collaboration and their role as trailblazers in innovative healthcare solutions.
At the event held in London’s Houses of Parliament, UNPCF Korea’s Chief Researcher, Jung Jaihoon, delivered an impactful presentation on cost-effective solutions for age-related diseases, garnering significant attention. Jung Jaihoon also emphasized the importance of new medical technologies for pandemic preparedness and showcased advancements in modern healthcare.
Looking ahead, U-Mine Korea plans additional presentations across Europe, the Middle East, and the United States, committed to introducing its groundbreaking biotechnology to the global market.
The innovative approaches of UNPCF Korea and U-Mine Korea, aimed at addressing the challenges of an aging society and enhancing global pandemic preparedness through biotechnology, position them at the forefront of the next wave in medical and biotechnological advancements.

在伦敦议会大厦举行的活动上,UNPCF Korea的首席研究员 Jung Jaihoon 发表了关于老年疾病的成本上的有效解决方案的演讲,受到高度关注。Jung Jaihoon 还强调了应对未来大流行病的新型医疗技术的重要性,并展示了现代医疗领域的进步。

